[Evaluation of the efficacy of a comprehensive programme of secondary prevention of cardiovascular disease in primary care: the PREseAP Study]
C Brotons, D Ariño, I Borrás, F Buitrago, M L González, P Kloppe, D Orozco, J M Pepió, P Rodríguez, A I Rodríguez, Equipo Investigador del Estudio PREseAP, C Brotons, D Ariño, I Borrás, F Buitrago, M L González, P Kloppe, D Orozco, J M Pepió, P Rodríguez, A I Rodríguez, Equipo Investigador del Estudio PREseAP
Abstract
Objectives: To assess the efficacy of a comprehensive secondary prevention programme to reduce morbidity and mortality in patients who have suffered a cardiovascular (CV) event; to control CV risk factors and prophylactic treatment in order to prevent recurrence; and to improve the quality of life of patients with cardiovascular disease.
Design: Randomised, pragmatic, open clinical trial in primary care.
Setting: A total of 42 primary care centres of 8 different areas in Spain.
Participants: Men and women below 86 years old, diagnosed with coronary disease and/or stroke and/or peripheral vascular disease in the preceding year, and who have no serious or terminal disease.
Intervention: Primary care centres will be randomised to following usual care (control group), or to following a comprehensive programme of secondary prevention (intervention group).
Main measurements: Cardiovascular fatal events, cardiovascular non-fatal events, total mortality and health-related quality of life (SF-36).
Source: PubMed